3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Myelodysplastic Syndromes
8
Lymphoma, Non-Hodgkin
6
Hodgkin Disease
6
Multiple Myeloma
5
Leukemia, Myelomonocytic, Chronic
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Lymphocytic, Chronic, B-Cell
4
Anemia, Refractory, with Excess of Blasts
4
Recurrence
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Large B-Cell, Diffuse
3
Lymphoma
3
Leukemia, Myeloid, Accelerated Phase
3
Leukemia
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Stomach Neoplasms
2
Sarcoma
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Pancreatic Neoplasms
2
Neoplasms, Germ Cell and Embryonal
2
Neoplasm, Residual
2
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Melanoma
2
Lymphoma, Follicular
2
Interventions
Gemcitabine
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
10
pembrolizumab
8
Cisplatin
8
enfortumab vedotin
5
Radiation
5
Mitomycin
5
Fluorouracil
5
avelumab
4
Cystoscopy
4
durvalumab
3
dehydroftorafur
3
Transurethral Resection of Bladder
3
Radiotherapy
3
Platinum
3
Nivolumab
3
Mitozytrex
3
Cystectomy
3
1,2-diaminocyclohexaneplatinum II citrate
3
ulixertinib
2
tremelimumab
2
erdafitinib
2
cabozantinib
2
atezolizumab
2
X-Rays
2
Paclitaxel
2
Immunoglobulin G
2
Docetaxel
2
Disulfides
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urinary Bladder Neoplasms
×
fludarabine phosphate
×
30 days
×
Clear all
No trials found.